These engineered OMVs not only recruited cytotoxic T lymphocytes (CTLs) to the tumor site but also induced interferon-gamma (IFN-γ) secretion, resulting in improved anticancer effects in a mouse colon cancer model. The gene discussed is IFNG; the disease is malignant colon neoplasm.